297 related articles for article (PubMed ID: 24980564)
1. Basal cell carcinoma-treatments for the commonest skin cancer.
Berking C; Hauschild A; Kölbl O; Mast G; Gutzmer R
Dtsch Arztebl Int; 2014 May; 111(22):389-95. PubMed ID: 24980564
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of basal cell carcinoma].
Schmitz L; Dirschka T
Hautarzt; 2016 Jun; 67(6):483-99. PubMed ID: 27206448
[TBL] [Abstract][Full Text] [Related]
3. [What is new in basal cell carcinoma?].
Heppt M; von Braunmühl T; Berking C
Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know.
Wiznia LE; Federman DG
Am J Med; 2016 Jul; 129(7):655-60. PubMed ID: 27046242
[TBL] [Abstract][Full Text] [Related]
5. Management of high-risk and advanced basal cell carcinoma.
Puig S; Berrocal A
Clin Transl Oncol; 2015 Jul; 17(7):497-503. PubMed ID: 25643667
[TBL] [Abstract][Full Text] [Related]
6. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
[TBL] [Abstract][Full Text] [Related]
8. Guidelines of care for the management of basal cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olencki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):540-559. PubMed ID: 29331385
[TBL] [Abstract][Full Text] [Related]
9. Inoperable infiltrative basal cell carcinoma successfully treated with vismodegib.
Zargari O; Azimi SZ; Geranmayeh S
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28631369
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Basal Cell Carcinoma.
Tanese K
Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
[TBL] [Abstract][Full Text] [Related]
11. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus.
Peris K; Licitra L; Ascierto PA; Corvò R; Simonacci M; Picciotto F; Gualdi G; Pellacani G; Santoro A
Future Oncol; 2015; 11(4):703-12. PubMed ID: 25686123
[TBL] [Abstract][Full Text] [Related]
12. Update of the European guidelines for basal cell carcinoma management.
Trakatelli M; Morton C; Nagore E; Ulrich C; Del Marmol V; Peris K; Basset-Seguin N;
Eur J Dermatol; 2014; 24(3):312-29. PubMed ID: 24723647
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck : First clinical experience with vismodegib for locally advanced disease.
Schulze B; Meissner M; Ghanaati S; Burck I; Rödel C; Balermpas P
Strahlenther Onkol; 2016 Jan; 192(1):25-31. PubMed ID: 26449347
[TBL] [Abstract][Full Text] [Related]
14. Interventions for basal cell carcinoma of the skin.
Bath-Hextall FJ; Perkins W; Bong J; Williams HC
Cochrane Database Syst Rev; 2007 Jan; (1):CD003412. PubMed ID: 17253489
[TBL] [Abstract][Full Text] [Related]
15. [Locally advanced basal-cell carcinoma: Combined alternative treatments beyond surgery].
Amici JM; Beylot-Barry M
Ann Chir Plast Esthet; 2015 Aug; 60(4):321-5. PubMed ID: 25708732
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
17. Vismodegib in the treatment of advanced BCC.
O'Kane GM; Lyons T; McDonald I; Mulligan N; Moloney FJ; Murray D; Kelly CM
Ir Med J; 2014; 107(7):215-6. PubMed ID: 25226719
[TBL] [Abstract][Full Text] [Related]
18. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
Dessinioti C; Plaka M; Stratigos AJ
Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
[TBL] [Abstract][Full Text] [Related]
19. [Basal cell carcinoma].
Takenouchi T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
[TBL] [Abstract][Full Text] [Related]
20. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
